Table 2.

Detailed information about patients misclassified by our predictive model

Patient IDBCR-ABL1 % at diagnosisBCR-ABL1 % at 3 moSokal scoreELTSBCR-ABL1 transcript typeTKIsMMR by 12 moMR4.5 by 5 yWithdrawal
EMR failure patients (n = 4) classified as low risk
 145* 5514IntIntb2a2IMN/AN/AYes
 1098531HighHighb3a2IM, NILNoYesNo
 10212413LowLowb3a2IMYesNoNo
 1707318LowLowb3a2IM, NILNoYesNo
EMR achievement patients (n = 2) classified as high risk
 183891.50IntIntb2a2IM, NILNoNoNo
 159866.90HighHighb3a2IM, NILNoNoNo
  • IM, imatinib; int, intermediate; N/A, not applicable; NIL, nilotinib.

  • * Withdrawn at 6 months because of poor patient compliance.